About
Shorla Oncology develops and commercializes oncology drugs focusing on treatment areas with limited or inadequate existing options, including pediatric oncology indications such as acute lymphoblastic leukemia. The company operates from Ireland with a US office in Cambridge, MA.
Explore Shorla Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.